Skip to main content
Clinical Trials/NL-OMON32965
NL-OMON32965RecruitingNot Applicable

Insulin sensitivity in adults with a mitochondrial disorder. - Insulin sensitivity in adults with mitochondrial disorder.

niversitair Medisch Centrum Sint Radboud0 sites14 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
14

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Adult patients with an inborn mitochondrial disorder due to a defect in the oxidative phosphorylation (OXPHOS).

Exclusion Criteria

  • diabetes mellitus, mental retardation or the use of drugs that influence glucose metabolism.

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Similar Trials

Terminated
Not Applicable
The acute effects of resistance exercise on insulin sensitvity.Type 2 diabetes and non-diabetic individualsMetabolic and Endocrine - Diabetes
ACTRN12608000289314RMIT University56
Completed
Not Applicable
Insulin sensitisation in post-menarcheal girls with a history of low birthweight and precocious pubarche: effects of the addition of antiandrogen treatment and of the androgen receptor length on body composition and endocrine-metabolic parametersOvarian hyperandrogenismUrological and Genital Diseases
ISRCTN08608368Hospital Sant Joan de Deu (Spain)20
Completed
Not Applicable
Studies of insulin action in patients at increased vascular risk: modulation by anti-hypertensive and endocrine replacement therapyHypertension, type two diabetes, hypopituitarismNutritional, Metabolic, EndocrineHypertension
ISRCTN84921696Royal Group Hospitals Trust (UK)45
Active, not recruiting
Phase 1
Studies of insulin action in patients at increased vascular risk. Modulation by antihypertensive and endocrine replacement therapy. - Studies of insulin action in patients at increased vascular riskProtocol (a): Essential Hypertension Protocol (b): Hypertension in Type 2 Diabetes Protocol (c): PanhypopituitarismMedDRA version: 8.1 Level: LLT Classification code 10022489 Term: Insulin resistance
EUCTR2006-001562-16-GBRoyal Group of Hospitals Trust45
Completed
Not Applicable
A study in subjects with impaired glucose tolerance (IGT) to evaluate effects of AO-128 on prevention of type 2 diabetes mellitus (Phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison)Impaired glucose tolerance (IGT)
JPRN-UMIN000001109Takeda Pharmaceutical Company Limited1,782